Clinical Trial Update: SpaceIT Hydrogel System for Perirectal Spacing [NA]

View source ↗

Summary

Boston Scientific’s SpaceIT Hydrogel System for perirectal spacing in prostate cancer radiotherapy is listed as active but not recruiting in the NCT06451614 tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SpaceIT Hydrogel System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING